People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2014 |
| Pulmatrix, Inc. | — | Pharmaceuticals | Series B | $62.9M | $86.2M | 2015 |
William Duke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Duke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| John Ryan | 1 | 17 |
| Todd Foley | 1 | 12 |
| Terrance McGuire | 1 | 9 |
| SCOTT ROCKLAGE | 1 | 9 |
| Michael Higgins | 1 | 9 |
| Robert Clarke | 1 | 7 |
| Ittai Harel | 1 | 6 |
| Kurt Graves | 1 | 5 |
| Daniel Pelak | 1 | 5 |
| Amit Munshi | 1 | 5 |
| MICHAEL J. HIGGINS | 1 | 4 |
| Mark Iwicki | 1 | 4 |
| Vaughn Kailian | 1 | 3 |
| Sean Traynor | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Hojabr Alimi | 1 | 3 |
| Sameer Harish | 1 | 3 |
| John Barr | 1 | 3 |
| Michael Bigham | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.